Might be a good time to post this with more people watching.The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation(full - 1998)Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation(full - 2000)Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells(full - 2001)Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma(full - 2006)9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer through Cdc2 Regulation(full - 2006)Anandamide inhibits adhesion and migration of breast cancer cells.(abstract - 2006)Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.(full - 2007)Endocannabinoids in endocrine and related tumours(full - 2008)JunD is involved in the antiproliferative effect of Delta(9)-tetrahydrocannabinol on human breast cancer cells(abstract - 2008)Cannabinoid receptor agonists inhibit growth and metastasis of breast cancer(abstract - 2008)Inhibition of Breast Cancer Aggressiveness by Cannabidiol(abstract - 2008)Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer(abstract - 2009)A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.(abstract - 2010)Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain.(abstract - 2008)Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.(full - 2009)Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain.(abstract - 2010)A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss.(abstract - 2010)Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1(full - 2004)Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1(full - 2008)Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth(full - 2007)The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway(full - 2008)Recent advances in the regulation of cholangiocarcinoma growth(full - 2010)Possible endocannabinoid control of colorectal cancer growth.(abstract - 2003)Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes.(abstract - 2004)The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2(full - 2005)Cannabinoids and cancer: potential for colorectal cancer therapy. (needs free registration)(abstract - 2005)Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon(full - 2007)Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor a–Mediated Ceramide De novo Synthesis in Colon Cancer Cells(full - 2008)Loss of cannabinoid receptor 1 accelerates intestinal tumor growth(full - 2008)Cannabinoids in intestinal inflammation and cancer(full - 2009)Induction of the antitumorigenic NSAID-activated gene (NAG-1) in synthetic hexahydrocannabinol-induced apoptosis of human colorectal cancer cells(abstract - 2009)Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells(abstract - 2010)Involvement of NSAID-activated gene-1 in a novel synthetic hexahydrocannabinol analogue-induced growth inhibition and apoptosis of colon cancer cells(abstract - 2010)The effect of cannnabinoid to gastric cancer(abstract -2006)Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.(abstract - 1998)Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors(full - 2000)Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.(abstract - 2000)Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1(full - 2001)Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors(full - 2001)Inhibition of tumor angiogenesis by cannabinoids(full - 2003)Cannabinoids: Potential Anticancer Agents(full - 2003)Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines(full - 2003)Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells(full - 2004)Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas(full - 2004)Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.(full - 2004)Hypothesis: Cannabinoid Therapy for the Treatment of Gliomas?(full - 2004)Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism(full - 2005)Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue(full - 2005)Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.(abstract - 2005)A pilot clinical study of Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.(full - 2006)The non-psychoactive Cannabidiol triggers caspase activation and oxidative stress in human glioma cells.(abstract - 2006)Cannabinoids Induce Glioma Stem-like Cell Differentiationand Inhibit Gliomagenesis(full - 2007)Expression of cannabinoid receptors and neurotrophins in human gliomas.(abstract - 2007)Targeting astrocytomas and invading immune cells with cannabinoids: a promising therapeutic avenue.(abstract - 2007)Delta9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.(full - 2007)Cannabinoids and gliomas.(full - 2007)Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression(full - 2008)Cannabinoids as potential new therapy for the treatment of gliomas(full - 2008)Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?(full - 2008)Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells.(full - 2009)Cannabidiol Enhances the Inhibitory Effects of ?9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival(full - 2010)Marijuana use and Risk of Oral Squamous Cell Carcinoma(full - 2004)Cannabis use and cancer of the head and neck: Case-control study(full -2008)A Population-Based Case-Control Study of Marijuana Use and Head and Neck Squamous Cell Carcinoma.(full - 2009)The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of humanKaposi‘s sarcoma cells in vitro(full - 2009)Effects of cannabinoids on L1210 murine leukemia. 1. Inhibition of DNA synthesis.(abstract - 1977)Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors(full - 2000)Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease(full - 2002)Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells.(abstract - 2003)Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway(full - 2005)Cannabidiol-Induced Apoptosis in Human Leukemia Cells : A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression(full - 2006){Delta}9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria(full - 2006)HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor(full - 2007)Enhancing the in vitro cytotoxic activity of Delta9-tetrahydrocannabinol in leukemic cells through a combinatorial approach(abstract - 2008)A pilot study of orally administered ?1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus(full - 1974)Antineoplastic activity of cannabinoids(full - 1975)In vivo effects of cannabinoids on macromolecular biosynthesis in Lewis lung carcinomas.(abstract - 1977)Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.(full - 1983)Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study(full - 2006)Marijuana Use and Lung Cancer: Results of a Case-Control Study(abstract - 2006){Delta}-9 Tetrahydrocannabinol inhibits growth and metastasis of lung cancer.(abstract - 2007)Delta(9)-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo(abstract - 2007)Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1(full - 2008)Doubts about the role of cannabis in causing lung cancer.(letter - 2008)Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors(full - 2000)The Peripheral Cannabinoid Receptor CB2 and CD40 Are Novel Biological Markers That Predict Outcome in Diffuse Large B-Cell Lymphoma of Elderly Patients.(abstract - 2004)Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.(abstract - 2005)Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma(full - 2006)Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation.(abstract - 2008)Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors(full - 2000)Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells.(abstract - 1998)Marijuana use and Risk of Oral Squamous Cell Carcinoma(full - 2004)Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study(full - 2006)Peripheral Cannabinoids Attenuate Carcinoma Induced Nociception in Mice(full - 2008)Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells(abstract - 2010)Cannabinoid receptors as a target for therapy of ovarian cancer(abstract - 2006)Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress–Related Genes(full - 2006)Cannabinoids in pancreatic cancer: Correlation with survival and pain(full - 2008)Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence for a Direct Role of Cannabinoids on Hormone Modulation at the Human Pituitary Level(full - 2001)delta-9-Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism(abstract - 1999)Suppression of Nerve Growth Factor Trk Receptors and Prolactin Receptors by Endocannabinoids Leads to Inhibition of Human Breast and Prostate Cancer Cell Proliferation(full - 2000)Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.(abstract - 2003)2-Arachidonoylglycerol A Novel Inhibitor of Androgen-Independent Prostate Cancer Cell Invasion(full - 2004)Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer(full - 2005)Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest(full - 2006)Cannabinoid receptors agonist WIN-55,212-2 inhibits angiogenesis, metastasis and tumor growth of androgen-sensitive prostate cancer cell CWR22R{nu}1 xenograft in athymic nude mice(abstract - 2007)Endocannabinoids in endocrine and related tumours(full - 2008)Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2(full - 2009)Cannabis and tobacco smoke are not equally carcinogenic(full - 2005)On the Carcinogenity of Marijuana Smoke(transcribed part - 1975)Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds(full - 2004)Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer(full - 2003)Intractable nausea and vomiting due to gastrointestinal mucosal metastases(abstract - 1997)Cannabinoid receptors as novel targets for the treatment of melanoma(full - 2006)Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases.(abstract - 2006)Cannabinoid receptor-1 modulation induces apoptosis of human melanoma cells(abstract - 2008)Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors(full - 2003)TESTICULAR CANCERCrossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy(abstract - 1986)Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth(full - 2001)Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis1(full - 2003)Endocannabinoids in endocrine and related tumours(full - 2008)Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.(abstract + introduction - 2008)A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis(abstract - 2009)Analgesic effect of delta-9-tetrahydrocannabinol.(full - 1975)Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate A prospective, randomized evaluation(abstract - 1979)Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double-blind cross-over trial against placebo(full transcribed - 1979)Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9--tetrahydrocannabinol.(full transcribed -1979)Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.(abstract - 1979)A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.(abstract - 1982)Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis(page 1 - 1986)Inhalation marijuana as an antiemetic for cancer chemotherapy.(full transcribed - 1988)Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy(page 1 - 1988)Dronabinol enhancement of appetite in cancer patients.(abstract - 1990)Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.(abstract - 1991)A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia(abstract -1994)Therapeutic Aspects of Cannabis and Cannabinoids(full - 2001)Targeting the endocannabinoid system in cancer therapy: A call for further research(full - 2002)Endocannabinoids in the immune system and cancer.(abstract - 2002)Cannabinoids: Potential Anticancer Agents(full - 2003)Inhibition of tumor angiogenesis by cannabinoids(full - 2003)Established and potential therapeutic applications of cannabinoids in oncology(page 1 - 2003)The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opioids(full - 2003)Cannabinoid receptor systems: therapeutic targets for tumour intervention(abstract - 2003)Cannabinoids and cancer: pros and cons of an antitumour strategy(full - 2006)Different views on the relationship between cannabinoids and cancer(full - 2006)The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients(abstract - 2006)A Cannabinoid Anticancer Quinone, HU-331, Is More Potent and Less Cardiotoxic Than Doxorubicin: A Comparative in Vivo Study(full - 2007)Sativex: Fact Sheet(full - 2007)Cannabinoids for Cancer Treatment: Progress and Promise(full - 2008)Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer(full - 2009)Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.(full - 2009)Hexahydrocannabinols, novel synthetic cannabinoid derivatives, suppress the tumor growth by inhibiting the VEGF secretion and angiogenesis(abstract - 2009)Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?(full - 2009)Cannabinoids in the treatment of cancer(full - 2009)Targeting the Endocannabinoid System for the Treatment of Cancer - A Practical View.(abstract - 2010)